GSK GlaxoSmithKline PLC ADRs
GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including respiratory and antiviral, vaccines, over-the-counter (OTC) medicines and health-related consumer products. This is an ADR of a company whose stock trades outside of the U.S. as the symbol LN:GSK.
$34.24 +0.15 (0.44%)
As of 03/03/2021 16:10:00 EST IEX book CBOE book
Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
ADRs
Large cap
Health Care
Drug Manufacturers—General
United Kingdom
United Kingdom
09/04/2001
2,508,519,780
8,311,204
$85,515,439,300
6.07%
SEC Edgar Online
20-F
37733W105
US37733W1053
2374112
ADRs
Large cap
Health Care
Drug Manufacturers—General
United Kingdom
United Kingdom
09/04/2001
2,508,519,780
8,311,204
$85,515,439,300
6.07%
SEC Edgar Online
20-F
37733W105
US37733W1053
2374112
Valuation (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
PB ratio:
PS ratio:
Return on equity:
Net income %:
34.46
14.17
2.54
39.41%
17.08%
14.17
2.54
39.41%
17.08%